Skip to main navigation Skip to search Skip to main content

A PROSPECTIVE, MULTICENTER,DOUBLE-BLIND,RANDOMIZED,COMPARATIVE STUDY TO EVALUATE THE EFFICACY,SAFETY AND TOLERABILITY...

Project: Research

Project Details

StatusFinished
Effective start/end date09/28/00 → 09/27/03

Funding

  • Merck and Company: $28,580.15